Use App
  • Trending
  • News
  • Earnings
DIADIA0.48%
SPYSPY0.10%
QQQQQQ1.12%
Trending
Top trending tickerSHIBSHIB11.46%
AVAXAVAX5.92%
ANTHZZXANTHZZX0.62%
JASMYJASMY0.53%
TAOTAO0.96%
REPLREPL7.27%
DVNDVN0.55%
XLEXLE0.40%
DOGDOG0.94%
TOSHITOSHI1.48%
Top trending tickerSHIBSHIB11.46%
AVAXAVAX5.92%
ANTHZZXANTHZZX0.62%
JASMYJASMY0.53%
TAOTAO0.96%
REPLREPL7.27%
DVNDVN0.55%
XLEXLE0.40%
DOGDOG0.94%
TOSHITOSHI1.48%

Feed

News

Sentiment

Fundamentals

Info

homeSymbolCVKD
Exchange: NASDAQ·Updated 06:52 PM EDT
CVKD logo

CVKDCadrenal Therapeutics, Inc.

$2.04
$0.01
(0.49%)
Today
·Closed $2.04
$0.0726
(3.56%)
After Hours
Mkt Cap$6.32M
Vol80,260.00

Fundamentals

Mkt Cap
$6.32M
Volume
-
52W High
$14.64
52W Low
$1.86
PE Ratio
-0.36
Avg. Volume
74,854.22
EPS (Annual)
-$6.64
P/B
2.85
Rev/Employee
$0.00
Earnings
-

Advertisement|Remove ads.

Latest CVKD News

View
CVKD Stock Retail Sentiment Peaks After FDA Clears Phase 3 Path For Blood Clot Drug
Stocktwits
Why Is Cadrenal Therapeutics Stock Drawing Retail Attention Today?
Stocktwits
Matthew Szot Sells 9,933 Shares of Cadrenal Therapeutics (NASDAQ:CVKD) Stock
MarketBeat
Loading...
Top Discussions
HIMSHIMS
$HIMS stock is tumbling today, reversing yesterday's rally, even after an FDA panel recommended adding several peptides to the compounding list. Are you buying the dip?
5
6
1.1K votes
SPYSPY
What do you think the S&P 500's ($SPY) return will be next week?
35
76
10.8K votes
HIMSHIMS
The FDA is deciding whether to add peptides to the compounding list, a ruling that could be huge for $HIMS. How do you think it goes?
5
2
524 votes

Advertisement|Remove ads.

TrendingNews
CommunityProfile